Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Clinical Endocrinology
|
April 9, 2008
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas
D Taïeb, L Tessonnier, F Sebag, et al.
World Journal of Surgery
|
February 11, 2010
Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?
D Taïeb, S Giusiano, F Sebag, et al.
Journal of Medical Genetics
|
February 27, 2004
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer
V Vasko, M Saji, E Hardy, et al.
The American Journal of Surgical Pathology
|
November 1, 1996
Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I
M F Le Bodic, M F Heymann, M Lecomte, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal
D Taïeb, F Sebag, B Farman-Ara, et al.
Clinical Endocrinology
|
September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
D Taïeb, F Sebag, M Cherenko, et al.
Clinical Endocrinology
|
November 3, 2010
Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities
N Charrier, A Deveze, N Fakhry, et al.
Diabetes & Metabolism
|
June 17, 2008
Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
A Bégu-Le Corroller, R Valéro, V Moutardier, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Clinical Endocrinology
|
April 9, 2008
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas
D Taïeb, L Tessonnier, F Sebag, et al.
World Journal of Surgery
|
February 11, 2010
Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?
D Taïeb, S Giusiano, F Sebag, et al.
Journal of Medical Genetics
|
February 27, 2004
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer
V Vasko, M Saji, E Hardy, et al.
The American Journal of Surgical Pathology
|
November 1, 1996
Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I
M F Le Bodic, M F Heymann, M Lecomte, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2010
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal
D Taïeb, F Sebag, B Farman-Ara, et al.
Clinical Endocrinology
|
September 23, 2008
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
D Taïeb, F Sebag, M Cherenko, et al.
Clinical Endocrinology
|
November 3, 2010
Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities
N Charrier, A Deveze, N Fakhry, et al.
Diabetes & Metabolism
|
June 17, 2008
Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients
A Bégu-Le Corroller, R Valéro, V Moutardier, et al.
Page
of 9